Latest Insider Transactions at Alector, Inc. (ALEC)
This section provides a real-time view of insider transactions for Alector, Inc. (ALEC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alector, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alector, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2021
|
Terrance Mcguire Director |
BUY
Other acquisition or disposition
|
Indirect |
111,666
+50.0%
|
-
|
|
Dec 21
2021
|
Terrance Mcguire Director |
SELL
Other acquisition or disposition
|
Indirect |
598,533
-51.94%
|
-
|
|
Dec 21
2021
|
Terrance Mcguire Director |
BUY
Other acquisition or disposition
|
Direct |
6,429
+50.0%
|
-
|
|
Dec 21
2021
|
Polaris Venture Management Co. Vi, L.L.C. |
SELL
Other acquisition or disposition
|
Direct |
98,533
-100.0%
|
-
|
|
Dec 21
2021
|
Polaris Venture Management Co. Vi, L.L.C. |
BUY
Other acquisition or disposition
|
Direct |
98,533
+50.0%
|
-
|
|
Dec 21
2021
|
Polaris Venture Management Co. Vi, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-3.89%
|
-
|
|
Dec 13
2021
|
Shehnaaz Suliman President and COO |
SELL
Open market or private sale
|
Direct |
75,000
-22.85%
|
$1,575,000
$21.45 P/Share
|
|
Dec 13
2021
|
Shehnaaz Suliman President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+29.69%
|
$1,275,000
$17.23 P/Share
|
|
Dec 10
2021
|
Shehnaaz Suliman President and COO |
SELL
Open market or private sale
|
Direct |
75,000
-22.6%
|
$1,650,000
$22.01 P/Share
|
|
Dec 10
2021
|
Shehnaaz Suliman President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+29.69%
|
$1,275,000
$17.23 P/Share
|
|
Dec 09
2021
|
Shehnaaz Suliman President and COO |
SELL
Open market or private sale
|
Direct |
75,000
-21.63%
|
$1,725,000
$23.1 P/Share
|
|
Dec 09
2021
|
Shehnaaz Suliman President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+29.69%
|
$1,275,000
$17.23 P/Share
|
|
Dec 08
2021
|
Shehnaaz Suliman President and COO |
SELL
Open market or private sale
|
Direct |
75,000
-23.92%
|
$1,650,000
$22.79 P/Share
|
|
Dec 08
2021
|
Shehnaaz Suliman President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+18.82%
|
$975,000
$13.74 P/Share
|
|
Dec 01
2021
|
Robert King Chief Development Officer |
SELL
Open market or private sale
|
Direct |
250
-0.05%
|
$5,000
$20.09 P/Share
|
|
Nov 11
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
55,000
-2.71%
|
$1,375,000
$25.0 P/Share
|
|
Nov 10
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
55,000
-2.64%
|
$1,375,000
$25.0 P/Share
|
|
Nov 09
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-2.33%
|
$2,500,000
$25.0 P/Share
|
|
Nov 08
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-2.28%
|
$2,500,000
$25.0 P/Share
|
|
Nov 05
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-2.22%
|
$2,500,000
$25.0 P/Share
|
|
Nov 04
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-2.18%
|
$2,500,000
$25.0 P/Share
|
|
Oct 01
2021
|
Robert King Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,967
+1.48%
|
-
|
|
Sep 23
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
9,625
-0.42%
|
$240,625
$25.1 P/Share
|
|
Sep 22
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-2.08%
|
$2,500,000
$25.7 P/Share
|
|
Sep 21
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-2.0%
|
$2,600,000
$26.32 P/Share
|
|
Sep 20
2021
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-1.92%
|
$2,600,000
$26.05 P/Share
|
|
Sep 10
2021
|
Kristine Yaffe |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$36,000
$18.1 P/Share
|
|
Aug 09
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
22,950
-4.47%
|
$619,650
$27.48 P/Share
|
|
Aug 09
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,950
+2.96%
|
$252,450
$11.82 P/Share
|
|
Aug 05
2021
|
Richard H Scheller |
SELL
Open market or private sale
|
Direct |
56,260
-96.99%
|
$1,519,020
$27.97 P/Share
|
|
Aug 05
2021
|
Richard H Scheller |
BUY
Exercise of conversion of derivative security
|
Direct |
56,260
+50.0%
|
$562,600
$10.14 P/Share
|
|
Jul 07
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
29,749
-3.88%
|
$1,130,462
$38.29 P/Share
|
|
Jul 07
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,749
+3.75%
|
$327,239
$11.82 P/Share
|
|
Jul 06
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-1.98%
|
$1,110,000
$37.71 P/Share
|
|
Jul 06
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+10.19%
|
$510,000
$17.15 P/Share
|
|
Jul 06
2021
|
Calvin Yu Vice President, Finance |
SELL
Open market or private sale
|
Direct |
3,334
-4.17%
|
$113,356
$34.65 P/Share
|
|
Jul 06
2021
|
Calvin Yu Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
3,334
+1.38%
|
$36,674
$11.82 P/Share
|
|
Jul 02
2021
|
Richard H Scheller |
SELL
Open market or private sale
|
Direct |
9,981
-100.0%
|
$309,411
$31.14 P/Share
|
|
Jul 02
2021
|
Robert King Chief Development Officer |
SELL
Open market or private sale
|
Direct |
60,000
-10.3%
|
$1,860,000
$31.14 P/Share
|
|
Jul 02
2021
|
Robert King Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+5.03%
|
$540,000
$9.15 P/Share
|
|
Jul 02
2021
|
Calvin Yu Vice President, Finance |
SELL
Open market or private sale
|
Direct |
110,840
-34.56%
|
$3,879,400
$35.58 P/Share
|
|
Jul 02
2021
|
Calvin Yu Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
60,840
+10.74%
|
$669,240
$11.82 P/Share
|
|
Jul 02
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-11.35%
|
$930,000
$31.14 P/Share
|
|
Jul 02
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,326
+6.15%
|
$294,542
$17.15 P/Share
|
|
Jul 01
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,726
-9.76%
|
$587,972
$22.23 P/Share
|
|
Jun 16
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,600
-1.65%
|
$101,200
$22.18 P/Share
|
|
Jun 16
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+1.63%
|
$46,000
$10.14 P/Share
|
|
Jun 15
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-9.88%
|
$660,000
$22.07 P/Share
|
|
Jun 15
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.81%
|
$270,000
$9.15 P/Share
|
|
Jun 08
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,175
-2.2%
|
$364,325
$19.91 P/Share
|